Elevated serum CA 19-9 levels in patients with pulmonary nontuberculous mycobacterial disease
| Autor: | Song Yee Kim, Sun Hee Jang, Joo Han Song, Se Kyu Kim, Kyung Soo Chung, Moo Suk Park, Young Sam Kim, Young Ae Kang, Ji Young Hong, Joon Chang |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
0301 basic medicine
Microbiology (medical) Adult Lung Diseases Male Tuberculosis CA-19-9 Antigen lcsh:QR1-502 Mycobacterium Infections Nontuberculous Mycobacterium abscessus lcsh:Microbiology lcsh:Infectious and parasitic diseases Elevated serum 03 medical and health sciences 0302 clinical medicine medicine Humans In patient Clinical significance lcsh:RC109-216 Nontuberculous mycobacteria Aged Aged 80 and over Medicine(all) biology business.industry Mycobacterial disease Middle Aged biology.organism_classification medicine.disease Anti-Bacterial Agents Biological marker 030104 developmental biology Infectious Diseases 030228 respiratory system Immunology Carbohydrate antigen 19-9 CA19-9 Drug Therapy Combination Female business Biomarkers |
| Zdroj: | Brazilian Journal of Infectious Diseases, Vol 20, Iss 1, Pp 26-32 (2016) Brazilian Journal of Infectious Diseases, Volume: 20, Issue: 1, Pages: 26-32, Published: FEB 2016 Brazilian Journal of Infectious Diseases v.20 n.1 2016 Brazilian Journal of Infectious Diseases Brazilian Society of Infectious Diseases (BSID) instacron:BSID |
| ISSN: | 1413-8670 |
| DOI: | 10.1016/j.bjid.2015.09.005 |
| Popis: | Increased serum CA 19-9 levels in patients with nonmalignant diseases have been investigated in previous reports. This study evaluates the clinical significance of serum CA 19-9 elevation in pulmonary nontuberculous mycobacterial disease and pulmonary tuberculosis. The median CA 19-9 level was higher in patients with pulmonary nontuberculous mycobacterial disease than in patients with pulmonary tuberculosis (pulmonary nontuberculous mycobacterial disease: 13.80, tuberculosis: 5.85, p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|